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Abstract. 
Opioid receptor antagonist naltrexone reduces alcohol consumption and relapse in both 
humans and rodents. The present study investigated whether hypothalamic 
proopiomelanocortin (POMC) neurons (producing beta-endorphin and melanocortins) play a 
role in alcohol drinking behaviors. Both male and female mice with targeted deletion of two 
neuronal Pomc enhancers nPE1 and nPE2 (nPE-/-), resulting in hypothalamic-specific POMC 
deficiency, were studied in short-access (4-h/day) drinking-in-the-dark (DID, alcohol in one 
bottle), intermittent access (IA, 24-hour cycles of alcohol access every other day, alcohol vs. 
water in a two-bottle choice), and alcohol deprivation effect (ADE) models. Wild-type nPE+/+ 
exposed to 1-week DID rapidly established stable alcohol drinking behavior with more intake in 
females, whereas nPE-/- mice of both sexes had less intake and less preference. Though nPE-
/- showed less saccharin intake and preference than nPE+/+, there was no genotype difference 
in sucrose intake or preference in the DID paradigm. After 3-week IA, nPE+/+ gradually 
escalated to high alcohol intake and preference, with more intake in females, whereas nPE-/- 
showed less escalation. Pharmacological blockade of mu-opioid receptors with naltrexone dose-
dependently reduced intake in nPE+/+, but had blunted effects in nPE-/- of both sexes. When 
alcohol was presented again after 1-week abstinence from IA, nPE+/+ of both sexes displayed 
significant increases in alcohol intake (ADE or relapse-like drinking), with more pronounced 
ADE in females, whereas nPE-/- did not show ADE in either sex. Our results suggest that 
neuronal POMC is involved in modulation of alcohol “binge” drinking, escalation and “relapse”, 
probably via hypothalamic-mediated mechanisms, with sex differences. 
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Introduction 
Alcohol alters the activity of the endogenous opioid peptide systems, especially the 
proopiomelanocortin (POMC) system.  POMC is a large peptide precursor that is cleaved to 
form several biologically active neuropeptides, including the potent opioid peptide beta-
endorphin, adrenocorticotropic hormone (ACTH), beta-lipotropin and alpha-melanocyte-
stimulating hormone. In the brain, a specialized population of neurons concentrated in the 
hypothalamic arcuate nucleus expresses POMC [Rubinstein et al. 1996; Cowley et al. 2001; de 
Souza et al. 2005; Zhou et al. 2013]. In the rat hypothalamus, alcohol increased POMC mRNA 
levels after 15 days of an alcohol-containing liquid diet [Angelogianni & Gianoulakis 1993]. 
Compared with Sardinian alcohol non-preferring (sNP) rats, there were higher basal POMC 
mRNA levels in the hypothalamus of Sardinian alcohol-preferring (sP) rats, and chronic alcohol 
exposure further increased hypothalamic POMC mRNA levels in sP rats [Zhou et al. 2013]. 
Taking into account the well-established role of beta-endorphin in reward-related and feeding 
behaviours [Koch et al. 2015], the genetically-determined POMC gene expression at basal 
levels and in response to alcohol exposure may contribute to the high alcohol preference and 
consumption observed in alcohol-preferring rats [Zhou et al. 2013] and mice [Jamensky & 
Gianoulakis 1999]. Decreased POMC mRNA and peptide levels were also reported in the rat 
hypothalamus after chronic alcohol exposure [Rasmussen et al. 2002; Navarro et al. 2013]. 
Acute alcohol administration stimulates the release of beta-endorphin in the nucleus 
accumbens [Marinelli et al. 2003]. Since activation of the mu-opioid receptor (MOP-r) by beta-
endorphin (the main endogenous ligand of MOP-r) is rewarding and increases dopamine 
release [Spanagel et al. 1991], beta-endorphin is involved in the reinforcing effects and 
motivational behaviors of alcohol [Koob & Kreek 2007; Roth-Deri et al. 2008]. Indeed, central 
beta-endorphin administration was found to induce conditioned place preference in rats [Amalric 
et al. 1987]. Numerous pharmacological studies provide strong evidence that opioid antagonists 
decrease alcohol reward, consumption, cue-induced reinstatement of alcohol seeking, and 
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relapse-like drinking in rodents and primates [Altschuler et al. 1980; Volpicelli et al. 1986; 
Heyser et al. 1999], as well as alcohol drinking, craving and relapse episodes in human 
alcoholics [O’Malley et al. 1992, 2002; Volpicelli et al. 1992].  Moreover, alcohol consumption is 
reduced in MOP-r knockout mice [Roberts et al. 2000; Hall et al. 2001; Becker et al. 2002], 
further suggesting that the MOP-r is involved in the regulation of alcohol drinking. 
Previous studies on the role of beta-endorphin in modulation of alcohol drinking using 
beta-endorphin deficient mice have been inconclusive.  For example, earlier publications 
reported no effect of a global knockout of pituitary and brain beta-endorphin on alcohol intake in 
mice [Grisel et al. 1999; Grahame et al. 2000]. However, in another study, beta-endorphin 
knockout mice were reported to show decreased alcohol consumption [Racz et al. 2008]. A 
limitation of this global beta-endorphin knockout mouse model is that it does not allow for 
clarification of which specific regions of POMC cells (e.g., hypothalamus) are involved in alcohol 
drinking behaviors. Recently, two neuronal Pomc enhancers (nPE1 and nPE2) that are 
necessary and sufficient for POMC expression specifically in hypothalamic arcuate neurons 
have been identified [de Souza et al. 2005]. Simultaneous transcriptional interference of nPE1 
and nPE2 enhancer function by insertion of a neomycin selection cassette in the enhancer 
vicinity abolishes POMC gene expression in the arcuate nucleus of transgenic mice, while 
leaving normal levels of POMC expression in pituitary cells [Bumaschny et al. 2012]. Therefore, 
to determine the role of hypothalamic POMC neurons in alcohol drinking behaviors in the 
present study, we used transgenic mice with region-specific POMC deficiency resulting from 
selective deletion of both nPE1 and nPE2 in combination with the neomycin insertion [Lam et al. 
2015].  Specifically, we determined the effect of tissue-specific Pomc gene manipulation on: (a) 
binge-like drinking in a 1-week drinking-in-the-dark model; (b) acquisition and escalation in a 
chronic (3-week) intermittent access drinking model of dependence-like behavior, and (c) 
relapse-like drinking in an alcohol deprivation effect model in both male and female mice. 
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MATERIALS AND METHODS 
[See Supplemental Information in detail] 
ANIMALS: [1] Pomc neuronal enhancers nPE1 and nPE2 knockout mice: The present study 
used intact, male and female, single-housed mice with targeted deletion of the POMC neuronal 
enhancers nPE1 and nPE2 (nPE-/-) [Lam et al. 2015]. The gene mutations were generated by 
homologous recombination in 129S6/SvEvTac Taffy ES cells to produce the chimeric founder 
mice, followed by 7-10 generations of backcrossing onto the C57BL/6J strain for the mice used 
in these studies. Specifically, in these transgenic mice, simultaneous deletion of nPE1 and 
nPE2 and insertion of a neomycin selection cassette in the enhancer vicinity in the context of 
the intact Pomc pituitary enhancer region and proximal promoter abolishes POMC gene 
expression in the arcuate nucleus, without altering POMC expression in pituitary cells. 
Consistent with this previous report, nPE-/- mice which lack hypothalamic POMC expression, 
had greater daily food intake in 3 measures at 8-9 weeks of age (5.3g in males and 5.4g in 
females, respectively) than nPE+/+ or nP+/- mice (~3.3g in males and 3.2g in females, 
respectively, for both genotypes). At the time the experiments started (age 8-10 weeks), nPE-/- 
mice had greater body weight (~ 40g and 35g in males and females, respectively) than nPE+/+ 
or nP+/- mice (~ 27g and 23g in males and females, respectively, for both genotypes). Such 
phenotypes are not shown until the age of 7-8 weeks. 
[2] Beta-endorphin deficient (B-END KO) mice: The mice were generated and described 
previously [Rubinstein et al. 1996]. A premature STOP codon was inserted into the coding 
region of exon 3 of Pomc, to prevent the translation of the N -terminal beta-endorphin peptide by 
homologous recombination in 129/Sv-derived D3 ES cells. The original chimeric founder was 
subsequently backcrossed onto the C57BL/6N strain for 5 generations and then onto the 
C57BL/6J strain for a minimum of 5 additional generations to produce the mice used in these 
studies. These mice have a global deletion of beta-endorphin peptides, but intact melanocortins 
and ACTH (including in the pituitary and hypothalamus).  
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EXPERIMENTS 
I. Effects of genotype and sex on alcohol (7.5%, 15% or 30%) drinking in a 4-day 
drinking-in-the-dark (DID) model in nPE and B-END mice. Based on the publication by Rhodes 
et al. (2005), the basic paradigm with our modifications was as follows: Starting at 3 hours after 
lights off, water bottles were replaced with 10-ml alcohol tubes filled with alcohol solution for 4 
hours [Zhou et al. 2016]. For 4 days, alcohol intake values were recorded daily after 4 hours of 
alcohol access. These data were used to calculate alcohol intake (i.e., g ⁄ kg). Genotype 
(nPE+/+, nPE+/- vs. nPE-/-) and sex (male vs. female) differences were then tested using this 
4-hour short access model (Table 1A). To further assess the genotype differences in alcohol 
preference, nPE+/+ and nPE-/- mice of both sexes were exposed to the 2-bottle “alcohol vs. 
water” free choice regimen on day 5, after 4 days of DID. In control experiments, sucrose (8% or 
16% [w/v]) or saccharin (0.1%, 0.2% or 0.4% [w/v]) was used in place of alcohol, with an 
otherwise identical procedure. For each concentration of alcohol, saccharin or sucrose, 
separate groups of transgenic mice were used to test the following behaviors: [1.1] Alcohol 
drinking in nPE; [1.2] Sucrose drinking in nPE; and [1.3] Saccharin drinking in nPE; as well as 
[1.4] Alcohol drinking in B-END knockout. 
II. Effects of genotype and sex on alcohol (15%) drinking in a 3-week intermittent access 
(IA) drinking model with acute administration of naltrexone, morphine or nor-binaltorphimine 
(nor-BNI) in nPE mice. 
The primary objective of the following experiments was to determine whether intermittent 
24-hour long access to alcohol for 3 weeks led to elevated alcohol intake and preference in 
each sex and genotype. The IA model used was similar to an earlier protocol [Hwa et al. 2011], 
with some modifications: mice had 24 hours of access to 15% alcohol every other day for 3 
weeks with food available at all times in a two-bottle free choice paradigm. For IA alcohol 
drinking [Experiment 2.1], the procedures were identical to those of the above DID model with 
the following exceptions: starting at 3 hours after lights off, both the water and 15% alcohol 
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tubes were placed on home cages for 24 hours. The left ⁄right position of the tubes was set up 
randomly. Alcohol and water intake values were recorded after 4, 8 and 24 hours of alcohol 
access on the drinking days. These data were used to calculate alcohol intake (i.e., g ⁄ kg) and 
relative preference for alcohol (i.e., alcohol intake ⁄ total fluid intake) (Table 1B). 
After 3 weeks of IA, the next objective was to determine whether there was potential 
genotype or sex difference in drinking behavior in the IA mice following mu- and kappa-opioid 
receptor activation or blockade (morphine, naltrexone or nor-BNI). Separate groups of mice 
were used for each dose of each compound in the following experiments: [2.2] IA with acute 
naltrexone (1 or 2 mg/kg); [2.3] IA with acute morphine (0.1 or 0.3 mg/kg); and [2.4] IA with 
acute nor-BNI (5 mg/kg). On the test day, 15% alcohol was presented after a single injection of 
the compound or vehicle, and then alcohol and water intake values were recorded at 4-, 8- and 
24-hour time points. 
III. Effects of genotype and sex on alcohol “relapse” drinking in an alcohol deprivation 
effect (ADE) model in nPE mice. In the baseline session, alcohol and water intake was recorded 
at 4, 8 and 24 hours after 3 weeks of IA. Alcohol bottles were then removed and presented 
again after 7 days of abstinence, at which point alcohol and water intake values were recorded 
in 2 post-abstinence sessions (on 2 consecutive days). We determined whether IA to alcohol for 
3 weeks led to the ADE with potential genotype and sex differences (Table 1C). 
IV. Effects of genotype and sex on basal corticosterone levels, analgesic threshold and 
locomotor activity in nPE mice. To determine genotype and sex differences in basal levels of the 
stress hormone corticosterone, blood samples from nPE+/+ and nPE-/- mice were collected 3 
hours after lights off (the time of the drinking sessions), and plasma corticosterone levels were 
assayed by radioimmunoassays. The thermal analgesic threshold was measured 3 hours after 
lights off in another set of nPE mice, by recording response latency (rear paw flutter, rear paw 
licking or jumping) at 52o C on the hot plate. Spontaneous locomotor activity was evaluated 3 
hours after lights off in another set of nPE mice of both sexes in a place conditioning apparatus 
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for 30 min. In the first of two tests, half the mice for each genotype were placed in the white 
chamber and half in the black one. In the second test, the chambers were switched. The 
average values of both tests were used as the locomotor activity score. 
Data analysis. In most experiments, group differences in alcohol (sucrose or saccharin) 
intake and preference ratios were analyzed using 2-, 3- or 4-way ANOVA for genotype, sex, 
time (hour, day or session) and treatments followed by Newman-Keuls post-hoc multiple 
comparison tests. The results of statistical analysis for all the figures and tables are provided in 
detail in the Supplemental Information. 
RESULTS 
I. Effects of genotype and sex on alcohol drinking in a DID model in nPE and B-END mice. 
1.1. Genotype and sex differences in alcohol intake and preference in nPE mice.  
Between genotypes, nPE-/- mice of both sexes drank less alcohol at every concentration 
tested than nPE+/+ mice over the 4-day DID experiment (Figure 1) [p<0.000001]. Over time, 
wild-type nPE+/+ mice of both sexes escalated their intake; in contrast, only male nPE-/- mice 
escalated their intake. Though 3-way ANOVA did not reveal any significant main effect of sex at 
15% alcohol, previous studies in mice have found sex differences in alcohol drinking behaviors 
[Racz et al. 2008; Hall et al. 2001; Hwa et al. 2011; Becker & Koob 2016]. Using these 
published findings as an a priori hypothesis, post-hoc results showed that nPE+/+ females had 
more 15% alcohol intake on day 3 than nPE+/+ males [p<0.05] (Figure 1B). At 30% 
concentration, nPE+/+ females consumed more alcohol than nPE+/+ males during the first 2 
days [p<0.05] (Figure 1C). When alcohol preference was tested on day 5 using a 4-h, 2-bottle 
(alcohol vs. water) choice paradigm, nPE-/- mice of both sexes had less preference than 
nPE+/+ mice at 7.5% and 15% concentrations [p<0.05] (Table 2A, 2B). However, heterozygous 
nPE+/- mice did not show any differences from nPE+/+ in either sex after exposure to 15% 
alcohol over the 4-day DID experiment (Figure 1 Additional Information in Supplementary 
Information). 
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1.2. No genotype or sex differences in sucrose drinking or preference. The specificity of 
the genotype differences on alcohol intake was tested using sucrose, another caloric reinforcer, 
with the same DID paradigm. During 4 days of 8% or 16% sucrose drinking, there was no 
genotype difference in either sex (Table S2), though there was a slight, but not significant, 
decrease in nPE-/- females at 16%. 
1.3. Genotype and sex differences in saccharin drinking and preference. The specificity 
of the genotype differences in alcohol intake was further tested by examining intake of non-
caloric reinforcer saccharin. nPE-/- mice of both sexes drank less 0.4% saccharin than nPE+/+ 
ones over the 4-day DID experiment [p<0.01], with apparent but non-significant reductions in 
intake at 0.1% and 0.2% concentrations (Table 3A, 3B). When saccharin preference was tested 
on day 5 using a 4-h, 2-bottle choice paradigm, nPE-/- mice of both sexes had less 0.2% 
saccharin preference than nPE+/+ mice [p<0.05] (Table 3C, 3D), with no genotype differences 
in 0.1% or 0.4% saccharin preference. Between sexes, nPE+/+ females had more saccharin 
intake than nPE+/+ males at 0.4% over the 4-day DID experiment [p<0.01] (Table 3A, 3B). 
1.4. Sex, but no genotype, differences in alcohol intake in B-END+/+ and B-END-/- mice. 
In the following experiments, the alcohol exposure procedure was identical to the above 
experiment. During 4 days of DID, there was no genotype difference in alcohol intake in either 
sex (Table S4), though B-END+/+ females showed more alcohol intake than B-END+/+ males 
at all alcohol concentrations tested [p<0.000001]. When 15% alcohol preference was tested on 
day 5, there was no genotype difference (data not shown). 
 
II. Effects of genotype and sex on alcohol (15%) drinking in an IA model with acute 
administration of naltrexone, morphine or nor-BNI in nPE mice. 
2.1 Genotype and sex differences in alcohol intake and preference in an IA model. 
nPE+/+ males exposed to the 2-bottle “alcohol (15%) vs. water” free choice regimen every other 
day for 3 weeks had more alcohol intake and higher preference ratios in session 10 than in 
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session 1 [p<0.00001] (Figure 2A, left). To test our a priori hypothesis that there were sex 
differences, we included the post-hoc result showing that nPE+/+ females had more intake than 
the nPE+/+ males in sessions 1 and 10 [p<0.01], even though 4-way ANOVA did not show any 
significant main effect of sex and session interaction (Figure 2A, right). In contrast, neither male 
nor female nPE-/- mice escalated their intake significantly over 3 weeks, with lower consumption 
[p<0.000001] and preference [p<0.000001] than nPE+/+ mice. 
To test if there were genotype or sex differences in alcohol consumption at other 
concentrations after 3 weeks of IA, the alcohol concentration was switched to 7.5% or 30% 
alcohol. In both sexes, nPE-/- mice had significantly less alcohol intake at both concentrations 
than nPE+/+ mice [p<0.000001] (Table S5A, S5B). Additionally, nPE+/+ females had more 
intake than nPE+/+ males at both concentrations [p<0.05]. 
2.2. Genotype differences in the effect of mu-opioid receptor antagonist naltrexone on 
alcohol drinking after IA.  Naltrexone at 1 mg/kg had no significant effect on alcohol intake or 
preference ratio in nPE+/+ or nPE-/- mice of either sex (Table S6). At 2 mg/kg, naltrexone 
reduced alcohol intake in nPE+/+ mice of both sexes, with a significant effect at 24 hours 
[p<0.01] (Table 4). In contrast, naltrexone did not reduce alcohol intake in nPE-/- mice of either 
sex. 
2.3. No genotype differences in the effect of mu-opioid receptor agonist morphine on 
alcohol drinking after IA.  Morphine at 0.1 mg/kg (Table S7) and 0.3 mg/kg doses (Table S8) 
had no effect on alcohol intake or preference in nPE+/+ or nPE-/- mice of either sex. 
2.4. Sex, but no genotype, differences in the effect of selective kappa-opioid receptor 
antagonist nor-BNI on alcohol drinking after IA.  At 5 mg/kg, nor-BNI significantly reduced 
alcohol intake at 24 hours in male mice of both genotypes [p<0.05] (Table S9A). In females, 
however, there was no effect of acute nor-BNI treatment on either genotype (Table S9B). 
 
III. Effects of genotype and sex on alcohol relapse-like drinking in an ADE model. 
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nPE+/+ mice of both sexes had significantly more alcohol intake at the 4-hour time point 
in the post-abstinence session 1 (P1) than in the baseline session (BL) [p<0.05] (Figure 3A). 
However, nPE-/- mice did not show this ADE, regardless of sex. To test our a priori hypothesis 
that there were sex differences, we included the post-hoc result showing that nPE+/+ females 
had more intake than nPE+/+ males in session P1 [p<0.05], even though 3-way ANOVA did not 
show any significant main effect of sex (Figure 3A).  There was no change in alcohol 
preference in either genotype at 4 hours (Figure 3B). There was no ADE observed at 8 or 24 
hours in either genotype (Table S10). 
 
IV. Effects of genotype and sex on basal corticosterone levels and analgesic threshold, but not 
locomotor activity in nPE mice. 
As shown in Table 5A, there were higher basal corticosterone levels in female nPE+/+ 
mice than in males of the same genotype [p=0.05]. Between the genotypes, nPE-/- mice had 
significantly higher basal corticosterone levels than nPE+/+ mice in each sex [p<0.005]. nPE+/+ 
females had a longer basal hot plate response than wild-type males [p<0.01], and nPE-/- mice 
had significantly shorter basal hot plate responses than nPE+/+ mice in each sex [p<0.05] 
(Table 5B). There were no sex or genotype differences in locomotor activity (Table 5C). 
DISCUSSION 
The main objective in this study was to investigate the potential role of hypothalamic-
specific POMC deficiency in alcohol drinking behaviors. Activation of POMC neurons affects 
food intake (which is increased and decreased by endorphin and melanocortins, respectively) 
especially at the onset of the dark cycle [Mercer et al. 2013], so we purposely monitored 
drinking activity at the beginning of the dark cycle using the DID model.  We found that nPE-/- 
mice of both sexes displayed lower alcohol intake than wild-type nPE+/+ mice during the 4-hour 
DID “binge” drinking (Figure 1), suggesting a contribution of basal hypothalamic POMC 
expression to the genetically determined tendency of nPE-/- mice towards reduced voluntary 
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alcohol consumption. Consistently, nPE-/- mice displayed less alcohol preference at 7.5% and 
15% (but not 30%) alcohol concentrations than nPE+/+ mice of both sexes (Table 2). When the 
blood alcohol concentration was measured after DID, nPE-/- males had significantly lower blood 
alcohol levels than nPE+/+ males (Table S1), which correlated with their reduced alcohol 
consumption levels, suggesting that differences in alcohol intake between the two genotypes 
resulted in altered blood alcohol levels. This result is consistent with earlier studies that found 
lower basal POMC mRNA levels in the hypothalamus of DBA/2 mice or sNP and ANA rats, 
which have low consumption and preference, than those in the hypothalamus of C57BL/6 mice 
or sP and AA rats, which have high consumption and preference [Jamensky & Gianoulakis 
1999; Marinelli et al. 2000; Zhou et al. 2013]. 
An issue with standard methods of measuring alcohol intake in terms of grams 
consumed/kilograms of body weight emerges when comparing groups with different body 
weights (e.g., genotype or sex). nPE-/- mice had greater body weights (~40%) than nPE+/+ 
mice, resulting in an exaggerated reduction in alcohol intake (g/kg). Similarly, males in general 
have greater body weight than females, with relatively less intake (g/kg). Of importance, nPE-/- 
mice showed less alcohol preference than nPE+/+ mice in both DID and IA models, which did 
not take into account the body weight differences between the genotypes. 
It is unlikely that the genotype differences between nPE-/- and nPE+/+ mice on alcohol 
intake were secondary to a general suppression of consumption behaviors. In fact, nPE-/- mice 
displayed higher food consumption, replicating results from a previous report [Bumaschny et al. 
2012]. In the DID paradigm, nPE deletion did not alter sucrose preference and only slightly 
reduced sucrose consumption without reaching statistical significance (Table S2). When both 
nPE-/- and nPE+/+ females were exposed to 15% alcohol in 0.1% saccharin, nPE-/- mice had 
less alcohol intake of and preference for the palatable alcohol/saccharin solution than the wild-
type, indicating that nPE deletion may not alter “alcohol-tasting” (Table S3). Further, the 
reduction of alcohol intake found in nPE-/- mice in the 2-bottle, free choice IA model was 
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coupled with a compensatory increase in water intake, clearly indicating the absence of 
nonspecific sedative behaviors, with normal locomotor activity (Table 5C). 
Consistent with a previous report using a 2-bottle choice paradigm [Grisel et al. 1999], 
the present study did not find any genotype differences in alcohol intake in either male or female 
B-END knockout mice using the DID paradigm (Table S4). Because 10-20 fold more beta-
endorphin is synthesized in the pituitary than in the hypothalamus [Zhou et al. 2013], global 
beta-endorphin deletion may affect pituitary functions more dramatically than hypothalamic 
ones. It is very possible that pituitary POMC may not be involved in certain alcohol-related 
behaviors. In our unpublished study, using Tpit knockout mice provided by Dr. Drouin (resulting 
in pituitary-specific POMC knock-out with intact hypothalamic POMC), we did not observe any 
differences in the DID model between Tpit-/- and wild-type in either males or females (n=7-8 for 
each genotype). Though our data were preliminary, they suggest that pituitary POMC is not 
involved in regulation of DID drinking behavior.  
The gradual increase in alcohol intake which results from long access to voluntary 
alcohol drinking is analogous to the loss of control over drug-taking found in human alcoholics 
[Koob 2008]. In nPE+/+ mice in the IA paradigm (intermittent 24-hour cycles of alcohol access) 
[Hwa et al. 2011], alcohol intake rapidly escalated over the course of weeks to high levels of 
consumption, with a parallel progressive elevation of alcohol preference (Figure 2). Therefore, 
we further tested the effect of hypothalamic POMC deletion on alcohol drinking during chronic 
escalation using an IA model, and found that nPE-/- mice showed less intake of and preference 
for 15% alcohol in both sexes than the wild-type (Figure 2). Our results suggest that the 
activation of hypothalamic POMC is involved in modulation of alcohol escalation drinking 
behavior. 
The phenomenon of a transient increase in alcohol consumption and/or preference after 
a period of imposed abstinence has been termed the alcohol deprivation effect (ADE) and has 
been observed in several species, including humans [Burish et al. 1981], rats and mice [Holter & 
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Spanagel 1999; Sajja & Rahman 2013]. Since the ADE in a long-term alcohol drinking model 
persists through very long abstinence phases (up to one year) and is hardly modified by 
external stimuli [Vengeliene et al. 2014], it can be regarded as an animal model of relapse 
behavior and craving with excellent predictive validity. In the present study, nPE+/+ mice of both 
sexes displayed the ADE with increased alcohol intake after 1 week of abstinence (Figure 3A). 
In contrast, nPE-/- mice had a blunted ADE in both sexes, suggesting the involvement of 
hypothalamic POMC in relapse-like drinking behavior. Consistently, in several different rodent 
studies [Holter & Spanagel 1999; Heyser et al. 2003], the ADE can be suppressed by 
naltrexone, a compound that is also effective in reducing relapse behavior in human alcoholics 
[O’Malley et al. 2002]. Because high baselines of the preference ratio in nPE+/+ mice were 
developed after 3 weeks of IA, it is possible that the ADE could not increase the preference ratio 
further when tested during post-abstinence sessions due to a ceiling effect (Figure 3B). 
In rats, chronic naltrexone (0.06 mg/kg) for 5 days was able to suppress the ADE only on 
the first post-abstinence day. Twenty-four hours after the last naltrexone injection, however, 
significant increases in alcohol consumption were observed [Heyser et al. 2003]. Similar results 
were reported after administering naloxone (1 mg/kg/h) in rats: reduced alcohol intake on post-
abstinence day 1, with an increase on day 2 (1 day after the last naloxone) [Holter & Spanagel 
1999]. These published results show a rebound increase in alcohol consumption in the post-
abstinence period after MOP-r blockade was discontinued. One possible explanation is that the 
MOP-r antagonists may enhance hypothalamic POMC function, as we recently reported 
increased POMC mRNA levels in the rat hypothalamus 24 hours after naloxone at 1 mg/kg 
[Zhou & Kreek 2015]. Based on these reasons, we purposely examined drinking activity on the 
2nd post-abstinence day in the present study, and found that nPE-/- mice did not show a 
rebound effect in the 2nd ADE test (Figure 3). Therefore, the observed reduction of ADE 
behaviours by hypothalamic POMC deletion is of interest, as it would constitute a clear piece of 
experimental evidence that hypothalamic POMC is responsible for relapse-like alcohol drinking. 
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Using the IA model, our current study confirmed that acute naltrexone administration 
dose-dependently (1-2 mg/kg) reduced alcohol intake and preference in the wild-type mice of 
both sexes [Hwa et al. 2011] (Table 4). These findings raise the possibility that alcohol may 
cause the release of endogenous beta-endorphin [Marinelli et al. 2003], which plays a functional 
role in alcohol drinking. Indeed, our study found that nPE-/- mice of both sexes had lower 
preference for 15% alcohol in both the DID (Table 2) and IA models (Figure 2), suggesting a 
reduced rewarding effect of alcohol when central POMC and beta-endorphin are reduced. In 
parallel, nPE-/- mice had significantly less saccharin (natural non-caloric reinforcer) intake and 
preference (Table 3) than the wild-type, suggesting that hypothalamic POMC deletion may 
produce an anhedonia-like state in nPE-/- mice. 
In line with the result on drinking behavior, the observation of decreased analgesic 
thresholds and increased corticosterone levels in nPE-/- mice (Table 5A, B) further indicates 
less beta-endorphin/MOP-r tone resulting from neuronal POMC deletion, as it is known that the 
beta-endorphin/MOP-r system plays modulatory roles in pain and hypothalamic-pituitary-adrenal 
activity in both humans and rodents [Rubinstein et al. 1996; O’Malley et al. 2002]. Because 
enkephalins can also bind and activate MOP-r, we purposely investigated whether naltrexone 
could affect alcohol drinking in nPE-/- mice lacking beta-endorphin, the main peptide ligand of 
MOP-r.  We observed no effect of acute treatment with 2 mg/kg naltrexone on alcohol drinking 
in the IA paradigm in either nPE-/- males or females (Table 4), though the same naltrexone 
treatment significantly reduced alcohol drinking in nPE+/+ mice.  Therefore, it is unlikely that 
enkephalins contribute much to the MOP-r mediated modulation of alcohol drinking. Our results 
agree with one earlier study showing that voluntary alcohol intake was not affected in 
enkephalin knockout mice [Racz et al. 2008]. For comparison with naltrexone, we tested the 
selective kappa-opioid receptor antagonist nor-BNI in nPE+/+ and nPE-/- mice and found that 
males of both the genotypes displayed similar reductions in intake after the blockade of kappa-
opioid receptors (Table S9), indicating no disruption of kappa function after the neuronal POMC 
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deletion. This also suggests that the lack of significant effect of naltrexone in nPE-/- males was 
not due to their lowered basal alcohol intake, as nor-BNI still significantly reduced their alcohol 
intake. Together, these findings suggest that POMC/beta-endorphin acting on MOP-r plays a 
critical role in alcohol drinking. 
Consistent with previous studies in mice [Racz et al. 2008; Hall et al. 2001; Hwa et al. 
2011] and rats (see a recent review by Becker & Koob in 2016), we confirmed sex differences in 
alcohol drinking, with higher alcohol intake in females. Furthermore, we observed that the 
genotype differences in alcohol consumption between nPE+/+ and nPE-/- mice was much 
greater in females than in males in the DID, IA and ADE models. The POMC deficiency affected 
female mice more strongly than males, suggesting that POMC may influence alcohol 
consumption in a sex-specific manner.  Our findings are in line with previous studies showing 
decreased voluntary alcohol intake in beta-endorphin and MOP-r knockout mice with more 
notable differences in females [Racz et al. 2008; Hall et al. 2001]. Sex differences have also 
been observed in human alcoholism: in a genetic study, the Pomc two-marker haplotype was 
associated with alcoholism in women, but not in men [Racz et al. 2008]. Our results further 
contribute to the idea that opioid regulation of alcohol dependence differs between sexes 
[Becker & Koob in 2016]. Additionally, there may be many physiological differences between 
sexes, such as metabolism [Burke et al. 2016], behavioral differences (like pain threshold) and 
endocrine systems (presented in the current study), that could underlie sex differences in 
alcohol-related behaviors. 
The role of endogenous melanocortins (encoded by the Pomc gene) in regulation of 
alcohol-related behavior is not clear. Pharmacological studies have found that activation of 
melanocortin 4 receptors (MC4) by specific agonists significantly reduced alcohol “binge”-like 
drinking in a DID model, with reduced appetitive and consumption behaviors [Sprow et al. 
2016]. A very recent study, however, found that MC4 receptor blockade in the ventral tegmental 
area reduced alcohol self-administration in rats [Shelkar et al. 2015], indicating that endogenous 
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melanocortins mediated the alcohol-reinforcing effect via MC4 activation, which is consistent 
with reports on other drugs of abuse [Hsu et al. 2005]. The present study also suggests that 
melanocortins and MC4 receptors may be involved in reduced alcohol drinking in hypothalamic 
POMC/melanocortin deficient mice. Further investigation of this is needed [Olney et al. 2014]. 
Summary: Use of a transgenic mouse line with tissue-specific deletion of POMC in 
hypothalamic neurons uniquely allowed us to explore the potential roles of hypothalamic POMC 
neurons in the context of multiple behavioral models of alcohol addiction (including DID, IA and 
ADE). Our studies clearly indicate an essential role of the POMC system in the regulation of 
alcohol-related behaviors in both male and female mice. This corroborates earlier studies 
showing that voluntary alcohol intake is decreased in MOP-r knockout mice lacking the receptor 
for the endogenous ligand beta-endorphin (produced in POMC neurons), with more pronounced 
effects in females. 
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Figure legends 
Figure 1. Genotype and sex differences in alcohol (7.5, 15 and 30%) intake in a 4-day drinking-
in-the-dark (DID) model in male (left) and female (right) nPE mice. Alcohol at 7.5% (A), 15% (B) 
or 30% (C) concentration was presented 3 hours after the beginning of dark cycle, and alcohol 
intake values (EtOH intake, g/kg) were recorded after 4 hours of alcohol access for 4 days in the 
nPE+/+ and nPE-/- mice. Genotype difference: *p<0.05, **p<0.01 or ***p<0.005 vs. nPE+/+ at 
the same day; Day difference: #p<0.05, ##p<0.01 or ###p<0.005 vs. the same genotype at day 
1 session; and Sex difference: &p<0.05 or &&p<0.01 vs. the same genotype on the same day 
by 3-way ANOVA with Newman-Keuls post-hoc tests (n=5-8 in nPE-/-; n=5-9 in nPE+/+). (A) 
7.5% alcohol: 3-way ANOVA revealed significant effects of genotype [F (1, 64) = 181, 
p<0.000001] and day [F (3, 64) = 25, p<0.00001], with no interaction between genotype and 
sex. Post hoc analysis showed that: (1) between genotypes, nPE-/- males had less intake than 
nPE+/+ ones on day 1, day 2 and day 4 [p<0.01 for all]; nPE-/- females had less intake than 
nPE+/+ ones on day 2, day 3 and day 4 [p<0.01 for all]; and (2) between the days,  nPE+/+ 
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males had more intake on day 4 than on day 1 [p<0.01]; nPE-/- males had more intake on day 3 
and day 4 than on day 1 [p<0.01 for both]; and nPE+/+ females had more intake on day 3 and 
day 4 than on day 1 [p<0.05 and p<0.01, respectively]. (B) 15% alcohol: 3-way ANOVA 
revealed significant effects of genotype [F (1, 104) = 156, p<0.000001], day [F (3, 104) = 9.7, 
p<0.00005] and interaction between genotype and sex [F (1, 104) = 9.9, p<0.005]. Post hoc 
analysis showed that: (1) between genotypes, nPE-/- males had less intake than nPE+/+ ones 
on day 2, day 3 and day 4 [p<0.05 for all]; nPE-/- females had less intake than nPE+/+ ones on 
day 2, day 3 and day 4 [p<0.001 for all]; and (2) between the days, nPE+/+ males had more 
intake on day 4 than on day 1 [p<0.05]; nPE+/+ females had more intake on day 2, day 3 and 
day 4 than on day 1 [p<0.05 for all]. Though overall sex difference was not significant, the post-
hoc showed that nPE+/+ females had more intake on day 3 than nPE+/+ males [p<0.05]. (C) 
30% alcohol: 3-way ANOVA revealed significant effects of genotype [F (1, 72) = 196, 
p<0.000001], day [F (3, 72) = 5.1, p<0.005], sex [F (1, 72) = 5.3, p<0.05], interaction between 
genotype and sex [F (1, 72) = 21, p<0.0001] and interaction between day and sex [F (3, 72) = 
5.7, p<0.005]. Post hoc analysis showed that: (1) between genotypes,  nPE-/- males had less 
intake than nPE+/+ ones on day 1, day 2 and day 4 [p<0.05 for all]; nPE-/- females had less 
intake than the nPE+/+ ones from day 1 to day 4 [p<0.005 for all]; (2) between the days, nPE+/+ 
males had more intake on day 3 and day 4 than on day 1 [p<0.05 and p<0.01, respectively]; 
nPE-/- males had more intake on day 3 and day 4 than on day 1 [p<0.05 for both]; and (3) 
between sex, nPE+/+ females had more intake on day 1 and day 2 than nPE+/+ males [p<0.01 
and p<0.05, respectively]. 
 
Figure 2. Genotype and sex differences in alcohol intake (A) and alcohol preference (B) in male 
(left) and female (right) nPE mice in a 3-week intermittent access (IA) drinking model. The mice 
were exposed to the 2-bottle “alcohol (15%) vs. water” choice regimen every other day for 3 
weeks. Data are presented after 4, 8 and 24 hours of alcohol access in session 1 on the first 
This article is protected by copyright. All rights reserved.
G2B 00097-2016 R2 
22 
 
day and in session 10 after 3 weeks of IA. Genotype difference: *p<0.05, **p<0.01 or *** 
p<0.005 vs. nPE+/+ at the same hour; Session difference: #p<0.05, ##p<0.01 vs. the same 
genotype at the same hour in session 1; and Sex difference: &&p<0.01 vs. the same genotype 
in the same session by 4-way ANOVA with Newman-Keuls post-hoc tests (n=5 in nPE-/-; n=5-8 
in nPE+/+). (A) Alcohol intake: 4-way ANOVA revealed significant effects of genotype [F (1, 
114) = 146, p<0.000001], session [F (1, 114) = 44, p<0.00001], sex [F (1, 114) = 13, p<0.0005], 
and interaction between genotype and sex [F (1, 114) = 6.9, p<0.01]. Post hoc analysis showed 
that: (1) in Session 1 between genotypes, nPE-/- males had less intake at 24 hours than nPE+/+ 
males [p<0.01]; nPE-/- females had less intake at 8 and 24 hours than nPE+/+ females [p<0.05 
and p<0.001, respectively]; (2) in Session 10 between genotypes, both nPE-/- males and 
females had less intake at 8 and 24 hours than nPE+/+ ones [p<0.01 for all]; and (3) between 
the Sessions, nPE+/+ males had more intake at 24 hours in Session 10 than in Session 1 
[p<0.05]. Though overall interaction between sex and session was not significant, nPE+/+ 
females had more intake at 24 hours than nPE+/+ males [p<0.01] in both Sessions 1 and 10. 
(B) Alcohol preference: 4-way ANOVA revealed significant effects of genotype [F (1, 114) = 70, 
p<0.000001] and session [F (1, 114) = 63, p<0.000001]. Post hoc analysis showed that: (1) in 
Session 1 between genotypes, both nPE-/- males and females had less preference at 8 hours 
than nPE+/+ ones [p<0.05]; (2) in Session 10 between genotypes, nPE-/- females had less 
preference at 4 hours than nPE+/+ ones [p<0.05]; and (3) between the Sessions, both nPE+/+ 
males and females had more preference at 4 hours in Session 10 than in Session 1 [p<0.01 and 
p<0.05, respectively]; and nPE-/- males had more preference at 4 and 24 hours in Session 10 
than in Session 1 [p<0.05 for both]. 
 
Figure 3. Genotype and sex differences in 15% alcohol intake (A) and preference (B) in male 
(left) and female (right) nPE mice in an alcohol deprivation effect (ADE) model at the 4-hour 
time point. In the baseline session (BL) after 3 weeks of intermittent access (IA) drinking, 
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alcohol and water intake values (EtOH intake, g/kg) were recorded after 4, 8 and 24 hours of 
alcohol access. After 7 days of abstinence, alcohol bottles were presented again and the 
alcohol and water intake were recorded for the 1st post-abstinence session (P1). The 2nd post-
abstinence session (P2) was 1 day later. Data in this figure is at the 4-hour time point. Genotype 
difference: *p<0.05 or ***p<0.005 vs. nPE+/+ in the same session; Session difference, #p<0.05 
or ##p<0.01 vs. the same genotype at the baseline session BL; and Sex difference: &p<0.05 vs. 
the same genotype in the same session by 3-way ANOVA with Newman-Keuls post-hoc tests 
(n=9-15 in nPE-/-; n=11-15 in nPE+/+). (A) Alcohol intake: 3-way ANOVA revealed significant 
effects of genotype [F (1, 138) = 58, p<0.000001], session [F (2, 138) = 8.8, p<0.005], 
interaction between genotype and sex [F (1, 138) = 6.6, p<0.05] and interaction between 
genotype and session [F (2, 138) = 3.9, p<0.05]. Post hoc analysis showed that: (1) In 
comparison with baseline session BL, nPE+/+ males and females had more intake in session 
P1 [p<0.05 and p<0.01, respectively]; and (2) between genotypes, nPE-/- males and females 
had less intake in session P1 than nPE+/+ ones [p<0.001 for both]; nPE-/- females had less 
intake in session P2 than nPE+/+ ones [p<0.05]. Though overall sex difference was not 
significant, nPE+/+ females had more intake in session P1 than nPE+/+ males [p<0.05]. (B) 
Alcohol preference: 3-way ANOVA revealed a significant effect of genotype [F (1, 138) = 19.9, 
p<0.00005]. Post hoc analysis showed that in session BL, nPE-/- males had less alcohol 
preference than nPE+/+ [p<0.05].  
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Table 1 Experimental timelines 
A. The 4-day alcohol drinking-in-the-dark (DID) model and alcohol preference (alcohol vs. 
water) on day 5 
Day 1 Day 2 Day 3 Day 4 Day 5 
4-h alcohol  4-h alcohol 4-h alcohol 4-h alcohol 4-h alcohol vs water 
 
B. The 3-week chronic intermittent access (IA) drinking model (15% alcohol vs. water) every 
other day with mu- (naltrexone) or kappa- (nor-BNI) opioid antagonist or morphine. 
Week 1 Week 2 Week 3 Week 4 
24-h alcohol 
vs water 
24-h alcohol 
vs water 
24-h alcohol 
vs water 
Naltrexone, nor-BNI, 
morphine 
 
C. The alcohol deprivation effect (ADE) model after 1-week abstinence from a 3-week chronic 
intermittent access (IA) drinking (15% alcohol vs. water) 
Week 1 Week 2 Week 3 Week 4 Week 5 
24-h alcohol 
vs water 
24-h alcohol 
vs water 
24-h alcohol 
vs water 
Baseline (BL) 
Alcohol abstinence ADE, alcohol vs 
water 
Post-abstinence (P) 
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Table 2. Genotype differences in alcohol (7.5, 15 or 30%) preference after 4 days of drinking-in-
the-dark (DID) in male (A) and female (B) nPE mice. On the test day, both alcohol (7.5%, 15% 
or 30% concentration) and water were presented 3 hours after the beginning of dark cycle, and 
alcohol and water intake values were recorded after 4 hours of alcohol access in the nPE+/+ 
and nPE-/- mice. Genotype difference: *p<0.05 vs. nPE+/+ by Student’s t-tests. 
2A. Males  
 7.5% alcohol 15% alcohol 30% alcohol 
Genotype nPE+/+ 
(n=5) 
nPE-/- 
(n=5) 
nPE+/+ 
(n=9) 
nPE-/- 
(n=8) 
nPE+/+ 
(n=5) 
nPE-/- 
(n=5) 
Alcohol  
Preference 
0.83±0.04 0.60±0.03 * 0.67±0.08 0.42±0.04 * 0.50±0.04  0.51±0.04 
 
 2B. Females 
 7.5% alcohol 15% alcohol 30% alcohol 
Genotype nPE+/+ 
(n=5) 
nPE-/- 
(n=5) 
nPE+/+ 
(n=6) 
nPE-/- 
(n=7) 
nPE+/+ 
(n=6) 
nPE-/- 
(n=6) 
Alcohol  
Preference 
0.85±0.03 0.54±0.02 * 0.61±0.06 0.24±0.07 * 0.55±0.07  0.59±0.02 
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Table 3. Genotype and sex differences in saccharin (0.1, 0.2 and 0.4%) intake in a 4-day 
drinking-in-the-dark (DID) model in male (A) and female (B) nPE mice, and in saccharin 
preference after the 4-day DID model in male (C) and female (D) nPE mice. In A and B, 
saccharin was presented 3 hours after the beginning of the dark cycle, and saccharin intake 
values were recorded after 4 hours of saccharin access for 4 days in the nPE+/+ and nPE-/- 
mice. In C and D, on the test day (day 5), both saccharin (0.1%, 0.2% or 0.4% concentration) 
and water were presented, and saccharin and water intake were recorded after 4 hours of 
saccharin access. Genotype difference: *p<0.05, **p<0.01 or ***p<0.005 vs. nPE+/+ on the 
same day; Sex difference: &&p<0.01 vs. the same genotype on the same day. 
At 0.1% or 0.2% saccharin, 3-way ANOVA did not show any differences between the 
genotypes, sexes or any effects of their interaction. At 0.4% saccharin, 3-way ANOVA revealed 
significant effects of genotype [F (1, 64) = 53, p<0.000001], sex [F (1, 64) = 56, p<0.000001], 
and interaction between genotype and sex [F (1, 64) = 43, p<0.00005]. Post hoc analysis 
showed that: (1) between genotypes, both nPE-/- males and females had less intake from day 1 
to day 4 than nPE+/+ ones [p<0.01 for all]; nPE-/- females had less intake at 8 and 24 hours 
than nPE+/+ ones [p<0.005 for both], and (2) between sexes, nPE+/+ males had less intake 
from day 1 to day 4 than nPE+/+ females [p<0.01 for all].  
3A. Saccharin intake in males (n=5) 
 Day 1  Day 2  Day 3  Day 4  
Genotype nPE+/+ nPE-/- nPE+/+ nPE-/- nPE+/+ nPE-/- nPE+/+ nPE-/- 
0.1%, g/kg 0.16± 
0.02 
0.10± 
0.03 
0.19± 
0.03  
0.08± 
0.02 
0.25± 
0.02  
 0.07± 
0.04 
0.28± 
0.03 
0.09± 
0.03 
0.2%, g/kg 0.29± 
0.03 
0.18± 
0.03  
0.31± 
0.02 
0.13± 
0.02  
0.48± 
0.08  
0.19± 
0.03  
0.53± 
0.07  
0.20± 
0.04  
0.4%, g/kg   0.65± 
0.08 && 
 0.32± 
0.07*  
0.69± 
0.10 &&  
0.38± 
0.08* 
 0.78± 
0.13 &&  
0.32± 
0.08* 
0.81± 
0.04 && 
0.33± 
0.08**  
 
 
3B. Saccharin intake in females (n=5) 
 Day 1  Day 2  Day 3  Day 4  
Genotype nPE+/+ nPE-/- nPE+/+ nPE-/- nPE+/+ nPE-/- nPE+/+ nPE-/- 
0.1%, g/kg 0.19± 
0.03   
0.04± 
0.01  
0.22± 
0.04 
 0.12± 
0.02  
0.25± 
0.01 
0.11± 
0.01 
0.23± 
0.02  
0.07± 
0.02  
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0.2%, g/kg 0.29± 
0.08 
0.24± 
0.05  
 0.54± 
0.05  
 0.22± 
0.05  
0.49± 
0.04  
0.23± 
0.04  
 0.53± 
0.02 
 0.12± 
0.04  
0.4%, g/kg 1.03± 
0.05  
0.38± 
0.08***  
1.03± 
0.08  
0.39± 
0.02***  
1.16± 
0.04  
0.36± 
0.07***  
1.07± 
0.06  
 0.31± 
0.08***  
 
 
3C. Saccharin preference in males (n=5). Genotype difference: *p<0.05 vs. nPE+/+ on 
the same day by Student’s t-tests.  
 0.1%  0.2%  0.4%  
Genotype nPE+/+ nPE-/- nPE+/+ nPE-/- nPE+/+ nPE-/- 
Preference 0.94±0.02 0.90±0.01 0.91±0.04 0.67±0.07 * 0.95±0.01  0.92±0.02 
 
 
3D. Saccharin preference in females (n=5). Genotype difference: *p<0.05 vs. nPE+/+ on 
the same day by Student’s t-tests.  
 0.1%  0.2%  0.4%  
Genotype nPE+/+ nPE-/- nPE+/+ nPE-/- nPE+/+ nPE-/- 
Preference 0.92±0.02 0.90±0.01 0.93±0.02 0.71±0.01 * 0.94±0.02  0.92±0.02 
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Table 4. Genotype differences in effects of acute naltrexone (NTN, 2 mg/kg) on alcohol (15%) 
intake and its preference in male (A) and female (B) nPE mice after 3 weeks of intermittent 
access (IA) drinking.  On the test day, 15% alcohol was presented 10 min after a single i.p. 
injection of NTN in saline or vehicle, and then alcohol and water intake values were recorded 
after 4, 8 and 24 hours of alcohol access. In the following experiments, mice in each sex were 
assigned to one of four treatment groups: (1) nPE+/+ with vehicle as control; (2) nPE+/+ with 2 
mg/kg NTN; (3) nPE-/- with vehicle as control; and (4) nPE-/- with 2 mg/kg NTN. Data are 
presented after 4, 8 and 24 hours of alcohol access. Genotype difference: *p<0.05 or *** 
p<0.005 vs. nPE+/+ mice at the same hour after the same treatment; Naltrexone treatment 
difference:  ##p<0.01or ###p<0.005 vs. vehicle control in the same genotype at the same hour 
by 4-way ANOVA with Newman-Keuls post-hoc tests. 
4A. Males 
Genotype  nPE+/+ (n = 6) nPE-/- (n = 5) 
Treatment  vehicle 2 mg/kg NTN vehicle 2 mg/kg NTN 
Intake 4h 7.6 ± 1.6 2.0 ± 0.7 2.9 ± 0.51 1.0 ± 0.08 
g/kg 8h 10.9 ± 2.2 5.8 ± 1.1 4.5 ± 0.8 * 2.8 ± 0.10 
 24h 21.4 ± 2.1 15.5 ± 1.3 ## 9.8 ± 2.2 *** 7.4 ± 0.7 
Preference 4h 0.86 ± 0.02 0.40 ± 0.13 0.68 ± 0.11 0.51 ± 0.10 
 8h 0.71 ± 0.04 0.54 ± 0.08 0.66 ± 0.12 0.53 ± 0.12 
 24h 0.67 ± 0.04 0.66 ± 0.06 0.58 ± 0.11 0.58 ± 0.13 
 
 4B. Females 
Genotype  nPE+/+  (n = 5) nPE-/- (n = 5) 
Treatment  vehicle 2 mg/kg NTN vehicle 2 mg/kg NTN 
Intake 4h 5.6 ± 0.79  4.1 ± 0.37  1.4 ± 0.57  1.2 ± 0.46  
g/kg 8h 12.0 ± 0.89 8.7 ± 0.64  2.9 ± 1.03 *** 3.3 ± 0.88 
 24h 24.4 ± 1.85 17.2 ± 1.3 ### 6.2 ± 1.9 *** 8.4 ± 1.8 
Preference 4h  0.81 ± 0.06  0.72 ± 0.08  0.51 ± 0.14  0.59 ± 0.08  
 8h 0.74 ± 0.07 0.68 ± 0.09 0.42 ± 0.14 0.53 ± 0.12 
 24h 0.65 ± 0.04 0.63 ± 0.07 0.42 ± 0.12 0.50 ± 0.11 
 
 Alcohol intake: 4-way ANOVA revealed significant effects of genotype [F (1, 102) = 181, 
p<0.000001], NTN treatment [F (1, 102) = 28, p<0.00005], interaction between genotype and 
sex [F (1, 102) = 4.2, p<0.05], interaction between genotype and NTN treatment [F (1, 102) = 
15, p<0.0005], and interaction between sex and NTN treatment [F (1, 102) = 4.9, p<0.05]. Post 
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hoc analysis showed that: (1) between genotypes, nPE-/- males and females had less intake at 
8 and 24 hours than nPE+/+ ones [p<0.05 and p<0.005, respectively]; and (2) NTN treatment at 
2 mg/kg reduced intake at 24 hours in nPE+/+ males and females [p<0.01 and p<0.005, 
respectively], but not in the nPE-/- ones. 
 Alcohol preference: 4-way ANOVA revealed significant effects of genotype [F (1, 102) = 
12, p<0.001], NTN treatment [F (1, 102) = 4.3, p<0.05], interaction between genotype and sex 
[F (1, 102) = 4.5, p<0.05], and interaction between sex and NTN treatment [F (1, 102) = 5.2, 
p<0.05]. 
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Table 5. Genotype and sex differences in basal plasma corticosterone levels (A), thermal 
analgesic thresholds (B), and spontaneous locomotor activity (C) in male and female alcohol 
naive nPE mice. (A) Blood was collected 3 hours after lights off and plasma corticosterone 
levels were assayed by radioimmunoassays; (B) The thermal analgesic threshold test was 
carried out on a hot plate at 52o C 3 hours after lights off and the time to response (rear paw 
flutter, rear paw licking or jumping) was measured; and (C) 3 hours after lights off, mice were 
placed into the appropriate chamber of conditioned place preference apparatus for 30 min, and 
locomotor activity was assessed as the number of “crossovers”. Genotype difference: *p<0.05 
or ***p<0.005 vs. nPE+/+ mice in the same sex; and Sex difference: &p=0.05 or &&p<0.01 v. 
nPE+/+ mice in the same genotype by 2-way ANOVA with Newman-Keuls post-hoc tests. 
 5A. Plasma corticosterone: Significant effects of genotype [F (1, 13) = 57.6, p<0.000005] 
and interaction between genotype and sex [F (2, 13) = 5.51, p<0.05]. Post hoc analysis showed 
that between genotypes, nPE-/- of both sex had higher plasma corticosterone levels than 
nPE+/+ [p<0.005 for both]. Though overall sex difference was not significant, nPE+/+ females 
nPE+/+ females had higher plasma corticosterone levels than nPE+/+ males [p=0.05]. 
5A males  females  
Genotype nPE+/+ (n=4) nPE-/- (n=5) nPE+/+ (n=5) nPE-/- (n=4) 
Corticosterone, ng/ml 41 ± 5 187 ± 10 *** 84 ± 25   & 162 ± 13 *** 
  
  
 5B. Hot plate responses: Significant effects of genotype [F (1, 29) = 18.8, p<0.0005] and 
sex [F (2, 29) = 17.5, p<0.0005]. Post hoc analysis showed that: (1) between genotypes, nPE-/- 
of both sexes had shorter responses than nPE+/+ [p<0.05 for both]; and (2) between sexes, 
nPE+/+ females had longer hot plate responses than nPE+/+ males [p<0.01]. 
5B males  females  
Genotype nPE+/+ (n=9) nPE-/- (n=8) nPE+/+ (n=9) nPE-/- (n=7) 
second 27 ± 4.1 14 ± 1.0 * 38 ± 2.3 && 26 ± 2.0 * 
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5C. Locomotor activity  
5C males  females  
Genotype nPE+/+ (n=8) nPE-/- (n=8) nPE+/+ (n=5) nPE-/- (n=5) 
Crossover (30 min) 273 ± 45 255 ± 27 280 ± 62 231 ± 59 
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